Drug intelligence / Profile preview

Cognium

Development stage
Unknown
Lead developer
Charak
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Cognium is a proprietary Ayurvedic formulation developed by Charak Pharmaceuticals, available in both tablet and syrup forms. It is designed to preserve and enhance cognitive functions, including memory, concentration, and attention span. Cognium contains a synergistic blend of traditional Ayurvedic herbs, including Brahmi (*Centella asiatica*), Jala Brahmi (*Bacopa monnieri*), Shankhapushpi (*Convolvulus pluricaulis*), Ashwagandha (*Withania somnifera*), Jyotishmati (*Celastrus paniculatus*), and Arjuna (*Terminalia arjuna*). These herbal ingredients work together to improve blood circulation to the central nervous system, protect neurons from oxidative stress, and act as adaptogens to mitigate mental fatigue and anxiety. It is commonly used by students, professionals, and individuals experiencing age-related cognitive decline or attention deficit hyperactivity disorder (ADHD).

Brand names
CogniumCognium SyrupCognium Tablet

Beyond the preview

Go deeper on Cognium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cognium.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call